Biotecnología
Biotecnología
CCRM Partners with Membio to Streamline Production of Viral Vectors for Cell and Gene Therapies
10/01/2023 -
Will explore combining Membio’s bioreactor system with CCRM’s virus producing cell line.
Viralgen Expands Capacity with cGMP Certification
10/01/2023 -
New facility in Spain operates single-use bioreactors from 50 to 2,000 liters and manufactures research, clinical and commercial grade rAAV vectors.
The AMR Action Fund Invests in BioVersys in Fight Against Drug-Resistant Bacteria
09/01/2023 -
Deal aims to advance its mission of enabling the launch of two to four antimicrobials by 2030.
Applied Cells Inc. and GenScript USA Enter Strategic Collaboration
23/11/2022 -
Will deliver combined cell isolation solutions for cell therapy drug development worldwide.
WuXi Vaccines Establishes New Vaccines CDMO Facility in China
16/11/2022 -
The 8,500-square-meter facility includes multiple 250L, 500L and 1000L single-use bioreactors as well as sterile drug-product manufacturing lines.
Gut Microbiome Therapy to be Approved in the Next Two Years
10/11/2022 -
The promise of microbiome-based therapeutics is rapidly progressing towards real world applications.
Alcohol Use Can Alter Gut Microbes, but Not in the Way You Might Think
12/08/2022 -
In mouse studies, UC San Diego researchers find that excess alcohol consumption alters gut microbiome but latter is not directly or significantly linked to liver disease.
Engineering the Microbiome to Potentially Cure Disease
05/08/2022 -
UC San Diego researchers report using native bacteria in mice as the chassis for delivering transgenes capable of inducing persistent and potentially even curative therapeutic changes in the gut and...
Giant Viruses Build a Cell Nucleus Surprisingly Like Our Own
04/08/2022 -
Scientists are using new technologies to obtain unprecedented looks inside viruses and their unique abilities to infect and destroy bacteria. Using cryo-EM and other technologies, they found that...
Univercells Technologies Partners with TFBS Bioscience
20/07/2022 -
TFBS will leverage scale-X carbo mid-scale fixed-bed bioreactor from Univercells for GMP viral vector operations at the CDMO’s New Taipei City facility.
Familiarity Breeds Exempt: Why Staph Vaccines Don’t Work in Humans
09/07/2022 -
UC San Diego researchers say they may have found the reason why multiple human clinical trials of staphylococcus vaccines have failed: the bacteria knows us too well.
A Rhythmic Small Intestinal Microbiome Prevents Obesity and Type 2 Diabetes
06/07/2022 -
UC San Diego researchers found that in mice how much they ate and when altered the nature of their gut microbiome: too much food too frequently resulted in poorer microbial and metabolic health.
With Roommates, It’s All About Chemistry, Molecularly Speaking
28/06/2022 -
UC San Diego researchers describe how the microbiomes of people and the homes they live in interact and change each other.
mAbxience Continues Manufacturing Capacity Expansion
06/06/2022 -
Secures its second 4,000L ABEC Custom Single Run (CSR) bioreactor to increase manufacturing capacity at its Leon, Spain facility.
Researchers Manipulate Demographic of Bacterial Community with Novel Electronic Technology
10/05/2022 -
Using second-long electrical shocks, UC San Diego scientists were able to control the types of cells in a community of bacteria. Being able to direct the ratio of cells holds implications for...
Scorpion Biological Services Unveils New Biomanufacturing Facility
29/04/2022 -
The $650mn commercial-scale facility will service approximately 144,000 liters of biomfg. capacity across 48 bioreactors.
MilliporeSigma Acquires MAST Platform from Lonza
08/04/2022 -
Automated, aseptic bioreactor sampling system designed to advance bioprocessing capabilities.
Sanofi, GSK to Seek Authorization for COVID-19 Vaccine
24/02/2022 -
Analysis of VAT02 booster trial confirms universal ability to boost neutralizing antibodies 18- to 30-fold across vaccine platforms (mRNA, adenovirus).
The Pistoia Alliance Launches Research Project Focused on Microbiomes
22/02/2022 -
Aims to gather all existing microbiome data to create a global standardized ‘atlas’ that scientists can refer to when choosing new drug candidates.
MaaT Pharma and Skyepharma Enter Manufacturing Partnership
11/02/2022 -
To establish the first exclusive microbiome ecosystem therapies cGMP manufacturing facility in France.
